|
Metaraminol Impurity 7
|
間胺醇雜質(zhì)7
|
501-53-1
|
|
Oxcarbazepine impurity 1
|
奧卡西平雜質(zhì)1
|
2642430-30-4
|
|
Olopatadine Impurity 40
|
奧洛他定雜質(zhì)40
|
113806-01-2
|
|
Orlistat Impurity 43
|
奧利司他雜質(zhì)43
|
104872-06-2
|
|
Omeprazole Impurity 38
|
奧美拉唑雜質(zhì)38
|
1424857-83-9
|
|
Oxacillin EP impurity f
|
苯唑西林EP雜質(zhì)F
|
5053-35-0
|
|
Olopatadine Impurity 39
|
奧洛他定雜質(zhì)39
|
1628639-06-4
|
|
Olmesartan Medoxomil Impurity 36
|
奧美沙坦酯雜質(zhì)36
|
95579-71-8
|
|
Olaparib Impurity 70
|
奧拉帕尼雜質(zhì)70
|
763114-04-1
|
|
Orlistat Impurity 47
|
奧利司他雜質(zhì)47
|
104872-28-8
|
|
Olaparib Impurity 69
|
奧拉帕尼雜質(zhì)69
|
1956340-97-8
|
|
Orlistat Impurity 45
|
奧利司他雜質(zhì)45
|
1072902-75-0
|
|
Olanzapine impurity 1
|
奧氮平雜質(zhì)1
|
1320360-86-8
|
|
Oxaliplatin EP Impurity D
|
奧沙利鉑EP雜質(zhì)D
|
61758-77-8
|
|
Olanzapine impurity 8
|
奧氮平雜質(zhì)8
|
639460-79-0
|
|
Pramipexole Impurity 36
|
普拉克索雜質(zhì)36
|
2489686-91-9
|
|
Pyronoprene Impurity 28
|
吡侖帕奈雜質(zhì)28
|
381233-79-0
|
|
Pregabalin Impurity89
|
普瑞巴林雜質(zhì)89
|
181289-38-3
|
|
Oxenalol
|
氧烯洛爾
|
6452-71-7
|
|
Olanzapine impurity 2
|
奧氮平雜質(zhì)2
|
1320360-87-9
|
|
Pregabalin Impurity 74
|
普瑞巴林雜質(zhì)74
|
501665-88-9
|
|
Olaparib Impurity 76
|
奧拉帕尼雜質(zhì)76
|
763114-25-6
|
|
Ondansetron EP Impurity G
|
昂丹司瓊(恩丹西酮)EP雜質(zhì)G
|
99614-03-6
|
|
Ondansetron EP Impurity A
|
昂丹司瓊(恩丹西酮)EP雜質(zhì)A
|
153139-56-1
|
|
Ondansetron EP Impurity C
|
昂丹司瓊(恩丹西酮)EP雜質(zhì)C
|
27387-31-1
|
|
L-Ornithine(Arginine EP Impurity C)
|
鳥氨酸(精氨酸EP雜質(zhì)C)
|
70-26-8
|
|
Oxymetazoline Hydrochloride EP impurity D
|
鹽酸羥甲唑啉EP雜質(zhì)D
|
55699-12-2
|
|
Ondansetron
|
昂丹司瓊
|
99614-02-5
|
|
Ondansetron EP Impurity B
|
昂丹司瓊(恩丹西酮)EP雜質(zhì)B
|
1076198-52-1
|
|
Oxymetazoline Hydrochloride EP impurity E
|
鹽酸羥甲唑啉EP雜質(zhì)E
|
55699-10-0
|
|
Ondansetron EP Impurity H
|
昂丹司瓊(恩丹西酮)EP雜質(zhì)H
|
99614-14-9
|
|
Ondansetron EP Impurity D
|
昂丹司瓊(恩丹西酮)EP雜質(zhì)D
|
99614-64-9
|
|
Ornidazole Impurity 4
|
奧硝唑雜質(zhì)4
|
62580-80-7
|
|
Ornidazole Impurity 7
|
奧硝唑雜質(zhì)7
|
14419-11-5
|
|
Ornidazole Impurity 22
|
奧硝唑雜質(zhì)22
|
31876-69-4
|
|
Oxymetazoline Hydrochloride EP impurity B
|
鹽酸羥甲唑啉EP雜質(zhì)B
|
526-36-3
|
|
Olaparib Impurity 75
|
奧拉帕尼雜質(zhì)75
|
2377912-28-0
|
|
Olaparib Impurity 73
|
奧拉帕尼雜質(zhì)73
|
42086-68-0
|
|
Nintedanib Impurity 12
|
尼達(dá)尼布雜質(zhì)12
|
1139458-48-2
|
|
Nilotinib EP Impurity H
|
尼羅替尼EP雜質(zhì)H
|
641571-15-5
|
|
Naproxen EP Impurity J
|
萘普生EP雜質(zhì)J
|
21388-17-0
|
|
Omeprazole
|
奧美拉唑
|
73590-58-6
|
|
Nifuzide
|
硝呋齊特
|
965-52-6
|
|
Non Sorodine Impurities1
|
非索羅定雜質(zhì)1
|
895137-81-2
|
|
Nafamostat Impurity 4
|
萘莫司他雜質(zhì)4
|
2241024-11-1
|
|
Naproxen EP Impurity H
|
萘普生EP雜質(zhì)H
|
5111-66-0
|
|
Naproxen EP Impurity M
|
萘普生EP雜質(zhì)M
|
93-04-9
|
|
Naproxen EP Impurity D
|
萘普生EP雜質(zhì)D
|
116883-62-6
|
|
Nilotinib Impurity 8
|
尼羅替尼雜質(zhì)8
|
2119583-27-4
|
|
Naproxen EP Impurity K
|
萘普生EP雜質(zhì)K
|
77301-42-9
|
|
Naproxen EP Impurity G
|
萘普生EP雜質(zhì)G
|
23979-41-1
|
|
Naproxen EP Impurity F
|
萘普生EP雜質(zhì)F
|
31220-35-6
|
|
Naproxen EP Impurity O
|
萘普生EP雜質(zhì)O
|
2471-70-7
|
|
Naproxen EP Impurity I
|
萘普生EP雜質(zhì)I
|
23981-47-7
|
|
Naproxen EP Impurity L
|
萘普生EP雜質(zhì)L
|
3900-45-6
|
|
N-nitrosoethanolamine
|
亞硝酸的N-（2-羥乙基）酰胺（尼可地爾雜質(zhì)4）
|
98033-27-3
|
|
Naproxen EP Impurity B
|
萘普生EP雜質(zhì)B
|
89617-86-7
|
|
Naproxen EP Impurity E
|
萘普生EP雜質(zhì)E
|
26159-35-3
|
|
Naproxen EP Impurity N
|
萘普生EP雜質(zhì)N
|
5111-65-9
|
|
Nintedanib impurity 56
|
尼達(dá)尼布雜質(zhì)56
|
262368-30-9
|
|
Nintedanib Impurity 30
|
尼達(dá)尼布雜質(zhì)30
|
894783-61-0
|
|
Nintedanib Impurity 29
|
尼達(dá)尼布雜質(zhì)29
|
54699-92-2
|
|
Nintedanib Impurity 34
|
尼達(dá)尼布雜質(zhì)34
|
1987887-92-2
|
|
Nidanib standard
|
尼達(dá)尼布標(biāo)準(zhǔn)品（尼達(dá)尼布標(biāo)準(zhǔn)品-CO）
|
2218446-42-3
|
|
Nintedanib Impurity 26
|
尼達(dá)尼布雜質(zhì)26
|
1160294-26-7
|
|
Nintedanib Impurity 27
|
尼達(dá)尼布雜質(zhì)27
|
2410284-90-9
|
|
Norethindrone Acetate EP Impurity G
|
醋酸炔諾酮EP雜質(zhì)G
|
438244-27-0
|
|
Naphazoline EP Impurity D
|
萘甲唑啉EP雜質(zhì)D
|
22126-67-6
|
|
Nintedanib Impurity 15
|
尼達(dá)尼布雜質(zhì)15
|
708279-23-6
|
|
Nilotinib EP Impurity C
|
尼羅替尼EP雜質(zhì)C
|
2458-12-0
|
|
Naphazoline Hydrochloride
|
鹽酸萘甲唑啉
|
550-99-2
|
|
Nintedanib Impurity 23
|
尼達(dá)尼布雜質(zhì)23
|
2093243-16-2
|
|
Nintedanib Impurity 16
|
尼達(dá)尼布雜質(zhì)16
|
78466-25-8
|
|
Nilotinib EP Impurity E
|
尼羅替尼EP雜質(zhì)E
|
2119583-26-3
|
|
Naphthalene
|
萘
|
91-20-3
|
|
Nilotinib EP Impurity B
|
尼羅替尼EP雜質(zhì)B
|
18595-18-1
|
|
Naphazoline Nitrate
|
硝酸萘甲唑啉
|
5144-52-5
|
|
Naphazoline EP Impurity C
|
萘甲唑啉EP雜質(zhì)C
|
132-75-2
|
|
Naphazoline EP Impurity B
|
萘甲唑啉EP雜質(zhì)B
|
86-87-3
|
|
Nicotinamide nucleoside impurities
|
煙酰胺核苷
|
146-77-0
|
|
Pyronoprene Impurity 25
|
吡侖帕奈雜質(zhì)25
|
543699-60-1
|
|
Nilotinib EP Impurity D
|
尼羅替尼EP雜質(zhì)D
|
641569-94-0
|
|
Nilotinib EP Impurity G
|
尼羅替尼EP雜質(zhì)G
|
917392-54-2
|
|
Nicotinamide EP Impurity C（Picolinamide）
|
尼克酰胺EP雜質(zhì)C(吡啶酰胺)
|
1452-77-3
|
|
Nintedanib
|
尼達(dá)尼布
|
656247-17-5
|
|
Nilotinib EP Impurity F
|
尼羅替尼EP雜質(zhì)F
|
2119583-24-1
|
|
Nicotinamide EP Impurity E
|
尼克酰胺EP雜質(zhì)E
|
1986-81-8
|
|
Nintedanib Impurity 22
|
尼達(dá)尼布雜質(zhì)22
|
676326-36-6
|
|
Nilotinib EP Impurity A
|
尼羅替尼EP雜質(zhì)A
|
641571-11-1
|
|
Nintedanib Impurity 21
|
尼達(dá)尼布雜質(zhì)21
|
1160293-24-2
|
|
Nicotinamide EP Impurity B（3-Cyanopyridine）
|
尼克酰胺EP雜質(zhì)B(3-氰基吡啶)
|
100-54-9
|
|
Nintedanib Impurity 14
|
尼達(dá)尼布雜質(zhì)14
|
2410649-54-4
|
|
Non Sorodine Impurities3
|
非索羅定雜質(zhì)3
|
1380491-71-3
|
|
Olmesartan Medoxomil Impurity 38
|
奧美沙坦酯雜質(zhì)38
|
1418133-31-9
|
|
Nintedanib Impurity 24
|
尼達(dá)尼布雜質(zhì)24
|
1438271-13-6
|
|
Naphazoline EP Impurity A
|
萘甲唑啉EP雜質(zhì)A
|
36321-43-4
|
|
Nintedanib Impurity 18
|
尼達(dá)尼布雜質(zhì)18
|
2514952-69-1
|
|
Napolimus impurities1（Nafamostat Impurity 1）
|
萘莫司他雜質(zhì)1
|
97457-78-8
|
|
Nintedanib Impurity 9
|
尼達(dá)尼布雜質(zhì)9
|
1860012-61-8
|
|
Nicotine EP Impurity A
|
尼古丁EP雜質(zhì)A
|
581-49-7
|
|
Olaparib Impurity 74
|
奧拉帕尼雜質(zhì)74
|
42086-73-7
|